Target intelligence / Profile preview

V-rel reticuloendotheliosis viral oncogene homolog A (avian) pseudogene

Molecular classification
Other (pseudogene, non-coding), not a receptor, enzyme, or transcription factor
01

Overview

ENSG00000227573, also called "v-rel reticuloendotheliosis viral oncogene homolog A (avian) pseudogene," is a human pseudogene. It is a non-coding genomic sequence related to the functional RELA gene but does not produce a protein product. Unlike functional RELA (p65), a subunit of the NF-κB transcription factor involved in inflammation and cancer, this pseudogene has no known direct biological or clinical significance as a therapeutic target[7][8]. Key clarification: If you are seeking information on the real molecular drug target, refer to the **RELA** gene or "Transcription factor p65" (NF-κB p65 subunit), which is a well-characterized transcription factor involved in immune response, inflammation, and cancer. The pseudogene should not be confused with this biologically and clinically relevant entity[7][8].

Other names
RELA pseudogeneV-Rel Reticuloendotheliosis Viral Oncogene Homolog A (Avian) (RELA) Pseudogene

Beyond the preview

Go deeper on V-rel reticuloendotheliosis viral oncogene homolog A (avian) pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-rel reticuloendotheliosis viral oncogene homolog A (avian) pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call